Subsequent research demonstrated that T-cells expressing CD4 and CD25 [the alpha chain of interleukin-2 (IL-2) receptor] from tumor-bearing mice abrogated tumor rejection10-.14 The gene discussed is CD4; the disease is neoplasm.